BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Davenport AP, Scully CCG, de Graaf C, Brown AJH, Maguire JJ. Advances in therapeutic peptides targeting G protein-coupled receptors. Nat Rev Drug Discov. 2020;19:389-413. [PMID: 32494050 DOI: 10.1038/s41573-020-0062-z] [Cited by in Crossref: 89] [Cited by in F6Publishing: 95] [Article Influence: 44.5] [Reference Citation Analysis]
Number Citing Articles
1 Yang J, Zhu Q, Wu Y, Qu X, Liu H, Jiang B, Ge D, Song X. Utilization of macrocyclic peptides to target protein-protein interactions in cancer. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.992171] [Reference Citation Analysis]
2 Shu C, Wang C, Chen S, Huang X, Cui J, Li W, Xu B. ERR-activated GPR35 promotes immune infiltration level of macrophages in gastric cancer tissues. Cell Death Discov 2022;8:444. [DOI: 10.1038/s41420-022-01238-4] [Reference Citation Analysis]
3 Anand U, Bandyopadhyay A, Jha NK, Pérez de la Lastra JM, Dey A. Translational aspect in peptide drug discovery and development: An emerging therapeutic candidate. BioFactors 2022. [DOI: 10.1002/biof.1913] [Reference Citation Analysis]
4 Rong G, Wang C, Hu J, Li Y, Cheng Y. Benzaldehyde-tethered fluorous tags for cytosolic delivery of bioactive peptides. Journal of Controlled Release 2022;351:703-712. [DOI: 10.1016/j.jconrel.2022.09.064] [Reference Citation Analysis]
5 Ripoll-sánchez L, Watteyne J, Sun H, Fernandez R, Taylor S, Weinreb A, Hammarlund M, Miller DM, Hobert O, Beets I, Vértes PE, Schafer WR. The neuropeptidergic connectome of C. elegans.. [DOI: 10.1101/2022.10.30.514396] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yang Z, Cheng J, Shang P, Sun J, Yu X. Emerging roles of olfactory receptors in glucose metabolism. Trends in Cell Biology 2022. [DOI: 10.1016/j.tcb.2022.09.005] [Reference Citation Analysis]
7 He Q, Cao H, Zhao Y, Chen P, Wang N, Li W, Cui R, Hou P, Zhang X, Ji M. DPP4 stabilizes integrin α4β1 complex to promote thyroid cancer cell metastasis by activating TGF-β signaling pathway. Thyroid 2022. [DOI: 10.1089/thy.2022.0317] [Reference Citation Analysis]
8 Akhunzada MJ, Yoon HJ, Deb I, Braka A, Wu S. Bell-Evans model and steered molecular dynamics in uncovering the dissociation kinetics of ligands targeting G-protein-coupled receptors. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-20065-2] [Reference Citation Analysis]
9 Chen JN, Jiang F, Wu YD. Accurate Prediction for Protein-Peptide Binding Based on High-Temperature Molecular Dynamics Simulations. J Chem Theory Comput 2022. [PMID: 36149394 DOI: 10.1021/acs.jctc.2c00743] [Reference Citation Analysis]
10 Ko DS, Kang J, Heo HJ, Kim EK, Kim K, Kang JM, Jung Y, Baek SE, Kim YH. Role of PCK2 in the proliferation of vascular smooth muscle cells in neointimal hyperplasia. Int J Biol Sci 2022;18:5154-67. [PMID: 35982907 DOI: 10.7150/ijbs.75577] [Reference Citation Analysis]
11 Eiden LE, Hernández VS, Jiang SZ, Zhang L. Neuropeptides and small-molecule amine transmitters: cooperative signaling in the nervous system. Cell Mol Life Sci 2022;79:492. [PMID: 35997826 DOI: 10.1007/s00018-022-04451-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Fox T, Bieler M, Haebel P, Ochoa R, Peters S, Weber A. BILN: A Human-Readable Line Notation for Complex Peptides. J Chem Inf Model 2022. [PMID: 35984937 DOI: 10.1021/acs.jcim.2c00703] [Reference Citation Analysis]
13 Zhong W, Barde S, Mitsios N, Adori C, Oksvold P, Feilitzen KV, O'Leary L, Csiba L, Hortobágyi T, Szocsics P, Mechawar N, Maglóczky Z, Renner É, Palkovits M, Uhlén M, Mulder J, Hökfelt T. The neuropeptide landscape of human prefrontal cortex. Proc Natl Acad Sci U S A 2022;119:e2123146119. [PMID: 35947618 DOI: 10.1073/pnas.2123146119] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
14 Darbalaei S, Chang RL, Zhou QT, Chen Y, Dai AT, Wang MW, Yang DH. Effects of site-directed mutagenesis of GLP-1 and glucagon receptors on signal transduction activated by dual and triple agonists. Acta Pharmacol Sin 2022. [PMID: 35953646 DOI: 10.1038/s41401-022-00962-y] [Reference Citation Analysis]
15 Monteleone S, Fedorov DG, Townsend-Nicholson A, Southey M, Bodkin M, Heifetz A. Hotspot Identification and Drug Design of Protein-Protein Interaction Modulators Using the Fragment Molecular Orbital Method. J Chem Inf Model 2022. [PMID: 35939049 DOI: 10.1021/acs.jcim.2c00457] [Reference Citation Analysis]
16 Rong G, Chen L, Zhu F, Tan E, Cheng Y. Polycatechols with Robust Efficiency in Cytosolic Peptide Delivery via Catechol-Boronate Chemistry. Nano Lett 2022. [PMID: 35900805 DOI: 10.1021/acs.nanolett.2c01810] [Reference Citation Analysis]
17 Chen Y, Zhou Q, Wang J, Xu Y, Wang Y, Yan J, Wang Y, Zhu Q, Zhao F, Li C, Chen C, Cai X, Bathgate RA, Shen C, Xu HE, Yang D, Liu H, Wang M. A unique peptide recognition mechanism by the human relaxin family peptide receptor 4 (RXFP4).. [DOI: 10.1101/2022.07.28.501832] [Reference Citation Analysis]
18 Farooq Z, Howell LA, Mccormick PJ. Probing GPCR Dimerization Using Peptides. Front Endocrinol 2022;13:843770. [DOI: 10.3389/fendo.2022.843770] [Reference Citation Analysis]
19 Behera LM, Ghosh M, Rana S. Deciphering the conformational landscape of few selected aromatic noncoded amino acids (NCAAs) for applications in rational design of peptide therapeutics. Amino Acids 2022. [PMID: 35723743 DOI: 10.1007/s00726-022-03175-z] [Reference Citation Analysis]
20 Xiong Y, Ke R, Zhang Q, Lan W, Yuan W, Chan KNI, Roussel T, Jiang Y, Wu J, Liu S, Wong AST, Shim JS, Zhang X, Xie R, Dusetti N, Iovanna J, Habib N, Peng L, Lee LTO. Small Activating RNA Modulation of the G Protein-Coupled Receptor for Cancer Treatment. Adv Sci (Weinh) 2022;:e2200562. [PMID: 35712764 DOI: 10.1002/advs.202200562] [Reference Citation Analysis]
21 Taghizadeh MS, Retzl B, Muratspahić E, Trenk C, Casanova E, Moghadam A, Afsharifar A, Niazi A, Gruber CW. Discovery of the cyclotide caripe 11 as a ligand of the cholecystokinin-2 receptor. Sci Rep 2022;12:9215. [PMID: 35654807 DOI: 10.1038/s41598-022-13142-z] [Reference Citation Analysis]
22 Moroy G, Tuffery P. Peptide-Based Strategies Against SARS-CoV-2 Attack: An Updated In Silico Perspective. Front Drug Discov 2022;2:899477. [DOI: 10.3389/fddsv.2022.899477] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Wang H, Qian T, Zhao Y, Zhuo Y, Wu C, Osakada T, Chen P, Ren H, Yan Y, Geng L, Fu S, Mei L, Li G, Wu L, Jiang Y, Qian W, Peng W, Xu M, Hu J, Chen L, Tang C, Lin D, Zhou J, Li Y. A toolkit of highly selective and sensitive genetically encoded neuropeptide sensors.. [DOI: 10.1101/2022.03.26.485911] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Pnueli L, Melamed P. Epigenetic repression of gonadotropin gene expression via a GnRH-mediated DNA delivery system. Gene Ther 2022. [PMID: 35301447 DOI: 10.1038/s41434-022-00325-6] [Reference Citation Analysis]
25 Harms M, Hansson RF, Carmali S, Almeida-Hernández Y, Sanchez-Garcia E, Münch J, Zelikin AN. Dimerization of the Peptide CXCR4-Antagonist on Macromolecular and Supramolecular Protraction Arms Affords Increased Potency and Enhanced Plasma Stability. Bioconjug Chem 2022. [PMID: 35293739 DOI: 10.1021/acs.bioconjchem.2c00034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Tomassi S, Dimmito MP, Cai M, D’aniello A, Del Bene A, Messere A, Liu Z, Zhu T, Hruby VJ, Stefanucci A, Cosconati S, Mollica A, Di Maro S. CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists. J Med Chem . [DOI: 10.1021/acs.jmedchem.1c01848] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Nicoli A, Dunkel A, Giorgino T, de Graaf C, Di Pizio A. Classification Model for the Second Extracellular Loop of Class A GPCRs. J Chem Inf Model 2022. [PMID: 35113559 DOI: 10.1021/acs.jcim.1c01056] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
28 Liccardo F, Luini A, Di Martino R. Endomembrane-Based Signaling by GPCRs and G-Proteins. Cells 2022;11:528. [DOI: 10.3390/cells11030528] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
29 Wang F, Liu M, Wang N, Luo J. G Protein-Coupled Receptors in Osteoarthritis. Front Endocrinol 2022;12:808835. [DOI: 10.3389/fendo.2021.808835] [Reference Citation Analysis]
30 Masucci MT, Minopoli M, Di Carluccio G, Motti ML, Carriero MV. Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer. Cancers (Basel) 2022;14:498. [PMID: 35158766 DOI: 10.3390/cancers14030498] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
31 Lee H, Sun R, Niehrs C. Uncoupling the BMP receptor antagonist function from the WNT agonist function of R-spondin 2 using the inhibitory peptide dendrimer RWd. J Biol Chem 2022;298:101586. [PMID: 35032551 DOI: 10.1016/j.jbc.2022.101586] [Reference Citation Analysis]
32 Chu S, Wang AL, Bhattacharya A, Montclare JK. Protein Based Biomaterials for Therapeutic and Diagnostic Applications. Prog Biomed Eng (Bristol) 2022;4:012003. [PMID: 34950852 DOI: 10.1088/2516-1091/ac2841] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
33 Kim D, Wu Y, Oh Y. Targeting cancer-associated fibroblasts in immunotherapy. Systemic Drug Delivery Strategies 2022. [DOI: 10.1016/b978-0-323-85781-9.00007-5] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Shi SM, Di L. Strategies to Optimize Peptide Stability and Prolong Half-Life. Peptide Therapeutics 2022. [DOI: 10.1007/978-3-031-04544-8_4] [Reference Citation Analysis]
35 Xie BJ, Duong VT. Therapeutic peptides: market and manufacturing. Peptide and Peptidomimetic Therapeutics 2022. [DOI: 10.1016/b978-0-12-820141-1.00030-3] [Reference Citation Analysis]
36 Zhang X, Chai Z, Lee Dobbins A, Itano MS, Askew C, Miao Z, Niu H, Samulski RJ, Li C. Customized blood-brain barrier shuttle peptide to increase AAV9 vector crossing the BBB and augment transduction in the brain. Biomaterials 2021;281:121340. [PMID: 34998171 DOI: 10.1016/j.biomaterials.2021.121340] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Vu O, Bender BJ, Pankewitz L, Huster D, Beck-Sickinger AG, Meiler J. The Structural Basis of Peptide Binding at Class A G Protein-Coupled Receptors. Molecules 2021;27:210. [PMID: 35011444 DOI: 10.3390/molecules27010210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Gupta MK, Beg M, Mohammad S. Editorial: Cell Biology, Physiology and Molecular Pharmacology of G Protein Coupled Receptors. Front Cell Dev Biol 2021;9:815291. [PMID: 34957128 DOI: 10.3389/fcell.2021.815291] [Reference Citation Analysis]
39 Lyapina I, Ivanov V, Fesenko I. Peptidome: Chaos or Inevitability. Int J Mol Sci 2021;22:13128. [PMID: 34884929 DOI: 10.3390/ijms222313128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Lucana MC, Arruga Y, Petrachi E, Roig A, Lucchi R, Oller-Salvia B. Protease-Resistant Peptides for Targeting and Intracellular Delivery of Therapeutics. Pharmaceutics 2021;13:2065. [PMID: 34959346 DOI: 10.3390/pharmaceutics13122065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
41 Mannes M, Martin C, Menet C, Ballet S. Wandering beyond small molecules: peptides as allosteric protein modulators. Trends Pharmacol Sci 2021:S0165-6147(21)00214-5. [PMID: 34857409 DOI: 10.1016/j.tips.2021.10.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Ren L, Gao Y, Cheng Y. A manganese (II)-based coordinative dendrimer with robust efficiency in intracellular peptide delivery. Bioact Mater 2022;9:44-53. [PMID: 34820554 DOI: 10.1016/j.bioactmat.2021.08.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
43 Zamolodchikova TS, Tolpygo SM, Kotov AV. From Agonist to Antagonist: Modulation of the Physiological Action of Angiotensins by Protein Conjugation-Hemodynamics and Behavior. Front Pharmacol 2021;12:772217. [PMID: 34803713 DOI: 10.3389/fphar.2021.772217] [Reference Citation Analysis]
44 Ma W, Chen Y, Xiong W, Li W, Xu Z, Wang Y, Wei Z, Mou T, Wu Z, Cheng M, Zou Y, Zhu Y, Zhou W, Liu F, Geng Y. STOML2 interacts with PHB through activating MAPK signaling pathway to promote colorectal Cancer proliferation. J Exp Clin Cancer Res 2021;40:359. [PMID: 34781982 DOI: 10.1186/s13046-021-02116-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Sachdev S, Cabalteja CC, Cheloha RW. Strategies for targeting cell surface proteins using multivalent conjugates and chemical biology. Methods Cell Biol 2021;166:205-22. [PMID: 34752333 DOI: 10.1016/bs.mcb.2021.06.004] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
46 Muratspahić E, Retzl B, Duerrauer L, Freissmuth M, Becker CFW, Gruber CW. Genome Mining-Based Discovery of Blenny Fish-Derived Peptides Targeting the Mouse κ-Opioid Receptor. Front Pharmacol 2021;12:773029. [PMID: 34744752 DOI: 10.3389/fphar.2021.773029] [Reference Citation Analysis]
47 Zeng Z, Ma C, Chen K, Jiang M, Vasu R, Liu R, Zhao Y, Zhang H. Roles of G Protein-Coupled Receptors (GPCRs) in Gastrointestinal Cancers: Focus on Sphingosine 1-Shosphate Receptors, Angiotensin II Receptors, and Estrogen-Related GPCRs. Cells 2021;10:2988. [PMID: 34831211 DOI: 10.3390/cells10112988] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
48 Li Y, Heng J, Sun D, Zhang B, Zhang X, Zheng Y, Shi WW, Wang TY, Li JY, Sun X, Liu X, Zheng JS, Kobilka BK, Liu L. Chemical Synthesis of a Full-Length G-Protein-Coupled Receptor β2-Adrenergic Receptor with Defined Modification Patterns at the C-Terminus. J Am Chem Soc 2021;143:17566-76. [PMID: 34663067 DOI: 10.1021/jacs.1c07369] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
49 Masoudi-Sobhanzadeh Y, Jafari B, Parvizpour S, Pourseif MM, Omidi Y. A novel multi-objective metaheuristic algorithm for protein-peptide docking and benchmarking on the LEADS-PEP dataset. Comput Biol Med 2021;138:104896. [PMID: 34601392 DOI: 10.1016/j.compbiomed.2021.104896] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
50 Maher S, Brayden DJ. Formulation strategies to improve the efficacy of intestinal permeation enhancers. Adv Drug Deliv Rev 2021;177:113925. [PMID: 34418495 DOI: 10.1016/j.addr.2021.113925] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
51 Nagaya A, Murase S, Mimori Y, Wakui K, Yoshino M, Matsuda A, Kobayashi Y, Kurasaki H, Cary DR, Masuya K, Handa M, Nishizawa N. Extended Solution-phase Peptide Synthesis Strategy Using Isostearyl-Mixed Anhydride Coupling and a New C-Terminal Silyl Ester-Protecting Group for N -Methylated Cyclic Peptide Production. Org Process Res Dev 2021;25:2029-38. [DOI: 10.1021/acs.oprd.1c00078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Liu H, Yan Z, Zhao Y, Ma X, Zhang H, Wang X, Zhuang W, Zheng Y, Liu B, Zhang L, Gao C. A Peptide Derived from IKK-Interacting Protein Attenuates NF-κB Activation and Inflammation. J Immunol 2021;207:1652-61. [PMID: 34426543 DOI: 10.4049/jimmunol.2100397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
53 Lei Y, Li S, Liu Z, Wan F, Tian T, Li S, Zhao D, Zeng J. A deep-learning framework for multi-level peptide-protein interaction prediction. Nat Commun 2021;12:5465. [PMID: 34526500 DOI: 10.1038/s41467-021-25772-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 20.0] [Reference Citation Analysis]
54 Zheng M, Wang R, Chen S, Zou Y, Yan L, Zhao L, Li X. Design, Synthesis and Antifungal Activity of Stapled Aurein1.2 Peptides. Antibiotics (Basel) 2021;10:956. [PMID: 34439006 DOI: 10.3390/antibiotics10080956] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Muratspahić E, Tomašević N, Nasrollahi-Shirazi S, Gattringer J, Emser FS, Freissmuth M, Gruber CW. Plant-Derived Cyclotides Modulate κ-Opioid Receptor Signaling. J Nat Prod 2021;84:2238-48. [PMID: 34308635 DOI: 10.1021/acs.jnatprod.1c00301] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
56 Mallick R, Basak S, Duttaroy AK. Fatty acids and evolving roles of their proteins in neurological, cardiovascular disorders and cancers. Prog Lipid Res 2021;83:101116. [PMID: 34293403 DOI: 10.1016/j.plipres.2021.101116] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
57 Chartier M, Desgagné M, Sousbie M, Rumsby C, Chevillard L, Théroux L, Haroune L, Côté J, Longpré JM, Boudreault PL, Marsault É, Sarret P. Pharmacodynamic and pharmacokinetic profiles of a neurotensin receptor type 2 (NTS2) analgesic macrocyclic analog. Biomed Pharmacother 2021;141:111861. [PMID: 34229249 DOI: 10.1016/j.biopha.2021.111861] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Muratspahić E, Tomašević N, Koehbach J, Duerrauer L, Hadžić S, Castro J, Schober G, Sideromenos S, Clark RJ, Brierley SM, Craik DJ, Gruber CW. Design of a Stable Cyclic Peptide Analgesic Derived from Sunflower Seeds that Targets the κ-Opioid Receptor for the Treatment of Chronic Abdominal Pain. J Med Chem 2021;64:9042-55. [PMID: 34162205 DOI: 10.1021/acs.jmedchem.1c00158] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
59 Clark AJ, Mullooly N, Safitri D, Harris M, de Vries T, MaassenVanDenBrink A, Poyner DR, Gianni D, Wigglesworth M, Ladds G. CGRP, adrenomedullin and adrenomedullin 2 display endogenous GPCR agonist bias in primary human cardiovascular cells. Commun Biol 2021;4:776. [PMID: 34163006 DOI: 10.1038/s42003-021-02293-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
60 Vahidinia Z, Joghataei MT, Beyer C, Karimian M, Tameh AA. G-Protein-Coupled Receptors and Ischemic Stroke: a Focus on Molecular Function and Therapeutic Potential. Mol Neurobiol 2021. [PMID: 34120294 DOI: 10.1007/s12035-021-02435-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
61 Wang X, Ni D, Liu Y, Lu S. Rational Design of Peptide-Based Inhibitors Disrupting Protein-Protein Interactions. Front Chem 2021;9:682675. [PMID: 34017824 DOI: 10.3389/fchem.2021.682675] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 16.0] [Reference Citation Analysis]
62 Wang Y, Lan Y, Yang X, Gu Y, Lu H. TGF-β2 upregulates tyrosinase activity via Opsin3 in human skin melanocytes in vitro. J Invest Dermatol 2021:S0022-202X(21)01242-2. [PMID: 34029574 DOI: 10.1016/j.jid.2021.01.040] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
63 Kozielewicz P, Shekhani R, Moser S, Bowin CF, Wesslowski J, Davidson G, Schulte G. Quantitative Profiling of WNT-3A Binding to All Human Frizzled Paralogues in HEK293 Cells by NanoBiT/BRET Assessments. ACS Pharmacol Transl Sci 2021;4:1235-45. [PMID: 34151213 DOI: 10.1021/acsptsci.1c00084] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
64 Kondo E, Iioka H, Saito K. Tumor-homing peptide and its utility for advanced cancer medicine. Cancer Sci 2021;112:2118-25. [PMID: 33793015 DOI: 10.1111/cas.14909] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
65 Gonçalves-Monteiro S, Ribeiro-Oliveira R, Vieira-Rocha MS, Vojtek M, Sousa JB, Diniz C. Insights into Nuclear G-Protein-Coupled Receptors as Therapeutic Targets in Non-Communicable Diseases. Pharmaceuticals (Basel) 2021;14:439. [PMID: 34066915 DOI: 10.3390/ph14050439] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
66 Liu J, Chen S, Chai XY, Gao F, Wang C, Tang H, Li X, Liu Y, Hu HG. Design, synthesis, and biological evaluation of stapled ascaphin-8 peptides. Bioorg Med Chem 2021;40:116158. [PMID: 33932712 DOI: 10.1016/j.bmc.2021.116158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
67 Hanser F, Marsol C, Valencia C, Villa P, Klymchenko AS, Bonnet D, Karpenko J. Nile Red-Based GPCR Ligands as Ultrasensitive Probes of the Local Lipid Microenvironment of the Receptor. ACS Chem Biol 2021;16:651-60. [PMID: 33733725 DOI: 10.1021/acschembio.0c00897] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
68 Ghanizada H, Al-Karagholi MA, Walker CS, Arngrim N, Rees T, Petersen J, Siow A, Mørch-Rasmussen M, Tan S, O'Carroll SJ, Harris P, Skovgaard LT, Jørgensen NR, Brimble M, Waite JS, Rea BJ, Sowers LP, Russo AF, Hay DL, Ashina M. Amylin Analog Pramlintide Induces Migraine-like Attacks in Patients. Ann Neurol 2021;89:1157-71. [PMID: 33772845 DOI: 10.1002/ana.26072] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 21.0] [Reference Citation Analysis]
69 Zhang XH, Tang LY, Wang XY, Shen CL, Xiong WF, Shen Y, Wan YH, Wu YB, Wang YC, Zhang HX, Lu SY, Fei J, Wang ZG. ADGRA1 negatively regulates energy expenditure and thermogenesis through both sympathetic nervous system and hypothalamus-pituitary-thyroid axis in male mice. Cell Death Dis 2021;12:362. [PMID: 33824276 DOI: 10.1038/s41419-021-03634-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
70 Yeo J, Peeva L, Chung S, Gaffney P, Kim D, Luciani C, Tsukanov S, Seibert K, Kopach M, Albericio F, Livingston A. Liquid Phase Peptide Synthesis via One-Pot Nanostar Sieving (PEPSTAR). Angew Chem Int Ed Engl 2021;60:7786-95. [PMID: 33444460 DOI: 10.1002/anie.202014445] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
71 Yang M, Zhang CY. G protein-coupled receptors as potential targets for nonalcoholic fatty liver disease treatment. World J Gastroenterol 2021; 27(8): 677-691 [PMID: 33716447 DOI: 10.3748/wjg.v27.i8.677] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
72 D'Aloisio V, Dognini P, Hutcheon GA, Coxon CR. PepTherDia: database and structural composition analysis of approved peptide therapeutics and diagnostics. Drug Discov Today 2021;26:1409-19. [PMID: 33647438 DOI: 10.1016/j.drudis.2021.02.019] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 23.0] [Reference Citation Analysis]
73 Yeo J, Peeva L, Chung S, Gaffney P, Kim D, Luciani C, Tsukanov S, Seibert K, Kopach M, Albericio F, Livingston A. Liquid Phase Peptide Synthesis via One‐Pot Nanostar Sieving (PEPSTAR). Angew Chem 2021;133:7865-74. [DOI: 10.1002/ange.202014445] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
74 Ciupe SM, Boribong BP, Kadelka S, Jones CN. Bistable Mathematical Model of Neutrophil Migratory Patterns After LPS-Induced Epigenetic Reprogramming. Front Genet 2021;12:633963. [PMID: 33708241 DOI: 10.3389/fgene.2021.633963] [Reference Citation Analysis]
75 Muttenthaler M, King GF, Adams DJ, Alewood PF. Trends in peptide drug discovery. Nat Rev Drug Discov 2021;20:309-25. [PMID: 33536635 DOI: 10.1038/s41573-020-00135-8] [Cited by in Crossref: 290] [Cited by in F6Publishing: 318] [Article Influence: 290.0] [Reference Citation Analysis]
76 Yang D, Zhou Q, Labroska V, Qin S, Darbalaei S, Wu Y, Yuliantie E, Xie L, Tao H, Cheng J, Liu Q, Zhao S, Shui W, Jiang Y, Wang MW. G protein-coupled receptors: structure- and function-based drug discovery. Signal Transduct Target Ther 2021;6:7. [PMID: 33414387 DOI: 10.1038/s41392-020-00435-w] [Cited by in Crossref: 70] [Cited by in F6Publishing: 79] [Article Influence: 70.0] [Reference Citation Analysis]
77 Kim D, Kim YS, Kim CS, Lee NK. Method for the Rapid Screening of Drug Candidates Using Single‐Protein Tracking in a Living Cell. Bull Korean Chem Soc 2021;42:393-7. [DOI: 10.1002/bkcs.12198] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 Clark AJ, Mullooly N, Safitri D, Harris M, de Vries T, Van Den Brink AM, Poyner DR, Giani D, Wigglesworth M, Ladds G. CGRP-receptor family reveals endogenous GPCR agonist bias and its significance in primary human cardiovascular cells.. [DOI: 10.1101/2020.12.21.423730] [Reference Citation Analysis]
79 Fukuhara S, Kobayashi K, Kusakizako T, Iida W, Kato M, Shihoya W, Nureki O. Structure of the human secretin receptor coupled to an engineered heterotrimeric G protein. Biochemical and Biophysical Research Communications 2020;533:861-6. [DOI: 10.1016/j.bbrc.2020.08.042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
80 Moll GN, Kuipers A, Rink R, Bosma T, de Vries L, Namsolleck P. Biosynthesis of lanthionine-constrained agonists of G protein-coupled receptors. Biochem Soc Trans 2020;48:2195-203. [PMID: 33125486 DOI: 10.1042/BST20200427] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
81 Kaiser A, Coin I. Capturing Peptide-GPCR Interactions and Their Dynamics. Molecules 2020;25:E4724. [PMID: 33076289 DOI: 10.3390/molecules25204724] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
82 Wu Y, Tam WS, Chau HF, Kaur S, Thor W, Aik WS, Chan WL, Zweckstetter M, Wong KL. Solid-phase fluorescent BODIPY-peptide synthesis via in situ dipyrrin construction. Chem Sci 2020;11:11266-73. [PMID: 34094367 DOI: 10.1039/d0sc04849f] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
83 Futaki S, Arafiles JVV, Hirose H. Peptide-assisted Intracellular Delivery of Biomacromolecules. Chem Lett 2020;49:1088-94. [DOI: 10.1246/cl.200392] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
84 Boo YC. Up- or Downregulation of Melanin Synthesis Using Amino Acids, Peptides, and Their Analogs. Biomedicines 2020;8:E322. [PMID: 32882959 DOI: 10.3390/biomedicines8090322] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
85 Ferré G, Eddy MT. Structural biology of human GPCR drugs and endogenous ligands - insights from NMR spectroscopy. Methods 2020;180:79-88. [PMID: 32911074 DOI: 10.1016/j.ymeth.2020.08.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
86 Rong L, Lei Q, Zhang X. Recent advances on peptide‐based theranostic nanomaterials. View 2020;1:20200050. [DOI: 10.1002/viw.20200050] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
87 Muratspahić E, Koehbach J, Gruber CW, Craik DJ. Harnessing cyclotides to design and develop novel peptide GPCR ligands. RSC Chem Biol 2020;1:177-91. [PMID: 34458757 DOI: 10.1039/d0cb00062k] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
88 Alexander SPH, Armstrong JF, Davenport AP, Davies JA, Faccenda E, Harding SD, Levi-Schaffer F, Maguire JJ, Pawson AJ, Southan C, Spedding M. A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development: IUPHAR Review 29. Br J Pharmacol 2020;177:4942-66. [PMID: 32358833 DOI: 10.1111/bph.15094] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 27.5] [Reference Citation Analysis]
89 An D, Peigneur S, Hendrickx LA, Tytgat J. Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products. Int J Mol Sci 2020;21:E5064. [PMID: 32709050 DOI: 10.3390/ijms21145064] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 24.0] [Reference Citation Analysis]
90 Lau J, Rousseau E, Kwon D, Lin KS, Bénard F, Chen X. Insight into the Development of PET Radiopharmaceuticals for Oncology. Cancers (Basel) 2020;12:E1312. [PMID: 32455729 DOI: 10.3390/cancers12051312] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
91 Venanzi M, Savioli M, Cimino R, Gatto E, Palleschi A, Ripani G, Cicero D, Placidi E, Orvieto F, Bianchi E. A spectroscopic and molecular dynamics study on the aggregation process of a long-acting lipidated therapeutic peptide: the case of semaglutide. Soft Matter 2020;16:10122-31. [DOI: 10.1039/d0sm01011a] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
92 Orsy G, Fülöp F, Mándity IM. Direct amide formation in a continuous-flow system mediated by carbon disulfide. Catal Sci Technol 2020;10:7814-8. [DOI: 10.1039/d0cy01603a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]